CBT-I or Zolpidem/Trazodone for Insomnia

Completed · Phase 4

Conditions studied: Chronic Insomnia

In brief

This study is a randomized (1:1:1) comparative effectiveness trial of medication (zolpidem or trazodone), cognitive-behavioral therapy for insomnia (CBT-I), and the combination (medication + CBT-I) for the treatment of chronic insomnia in men and women aged 18-80 living in rural areas with 1 year of follow-up. A total of 155 participants will be enrolled and randomized in the United States. This trial is funded by the Patient-Centered Outcomes Research Institute.

Key facts

Study ID
NCT04468776
Run by
California Pacific Medical Center Research Institute
People needed
155
Starts
2022-02-25
Expected to finish
2024-06-30
Last updated by the study team
2025-02-24

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.